Skip to content
Triangle logo TriangleGet started
← Cancer explorer

Lung cancer / Population context

A population, not a prediction.

Explore what a specific source population shows. These statistics cannot tell you what will happen to one person.

Choose a published population

No personal information is saved

Loading published population options… The default chart is available below.

These are source categories, not a patient profile. Different sources support different filters. Trial results are not adjusted by these selections.

Population context · SEER

Lung and bronchus cancer

Both Sexes · All Ages · All Stages · All Races / Ethnicities

21.5%5-year relative survival

All lung cancer types combined. This group is not specific to NSCLC, EGFR, PD-L1, or a treatment. It cannot be directly compared with the trial charts.

Relative survival after diagnosis Reported diagnosis years: 2000-2022
0%25%50%75%100%0246810Years after diagnosis

Points are published annual estimates; connecting lines only guide the eye. Vertical marks show 95% confidence intervals and may be very small. Relative survival compares observed survival with expected survival in a comparable general population; it is not the percentage of people alive.

All stages combined. These historical cohorts do not reflect only today’s treatments.

Exact data & source notes
Published relative survival estimates. Missing values are explicitly marked.
Year after diagnosisRelative survival95% CISource count*
0100.000000%Not published1,304,884
147.449925%47.361742–47.538053%1,304,884
233.749199%33.663844–33.834570%1,304,884
327.548567%27.465714–27.631476%1,304,884
423.963567%23.882083–24.045134%1,304,884
521.470511%21.389638–21.551490%1,304,884
619.600487%19.519591–19.681512%1,304,884
718.052687%17.971336–18.134191%1,304,884
816.738965%16.656756–16.821353%1,304,884
915.616915%15.533476–15.700560%1,304,884
1014.606958%14.521966–14.692188%1,304,884

*Source count is not a count of people still at risk at each year. Values are preserved as reported, not recalculated.

Sex recorded in source
Both Sexes
Age at diagnosis
All Ages
Stage at diagnosis
All Stages
Race / ethnicity in source
All Races / Ethnicities
Source release
seer-current-followup-55c51fbc7a045c99839e43b4
Source series
1_1_1_101_47_47

SEER 21 registries excluding Illinois · November 2025 submission. Source notes below are transcribed from the captured response.

  • For more details on SEER race/ethnicity groupings, please see Race and Hispanic Ethnicity Changes.
  • SEER Incidence Data, November 2025 Submission (1975-2023), SEER 21 registries (excluding Illinois).
  • Expected Survival Life Tables by Socio-Economic Standards.
  • The relative survival rates are calculated using monthly intervals.
  • Incidence data for Hispanics and Non-Hispanics are based on the NAACCR Hispanic Latino Identification Algorithm (NHIA).
  • Rates for American Indians/Alaska Natives only include cases that are in a Purchased/Referred Care Delivery Area (PRCDA).
  • See SEER*Explorer Cancer Site Definitions for details about the cancer site coding used for SEER Incidence data.
  • Stage at diagnosis is calculated using the Combined Summary Stage (2004+) recode, created from SEER Combined Summary Stage 2000 (2004-2017) & Derived Summary Stage 2018 (2018+). For more information, see the SEER documentation.

Original SEER response · data
Retrieved 2026-09-10 · SHA-256 df4ee08cbb478b3333d3c5de2ed6fb6fc0ec7a3b2ac6ea9fc690c149538cecbf

Original SEER response · population categories
Retrieved 2026-09-10 · SHA-256 6b6e18c78530f69b7edfba17df9af6d06f6d0f86f5feb504955da0d1c7293986

Permanent chart & citation ↗